Lyrica (Viatris Inc.)
(https://lyrica.com) 📸 Data Snapshot: May 31, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
The site contains a Trust Theatre anomaly where the JSON-LD schema indicates a review_count of 1, yet no actual patient reviews or verified testimonials are present in the text, creating an unverified proof signal. While the site claims to be FDA approved, it fails to provide direct links to the underlying clinical trial data or peer-reviewed studies within the landing page body text, forcing users to hunt through external Prescribing Information links. The absence of specific efficacy percentages (e.g., percent of patients achieving 50% pain reduction) makes the ‘FDA approved’ tag feel like a marketing shield rather than a clinical proof point.
The proof density is extremely low, with the only verifiable data point being the $4 savings card eligibility. Across four pages, there are zero citations of peer-reviewed journals or ClinicalTrials.gov identifiers in the main body text. The ratio of vague assertions (e.g., ‘may help you’) to hard clinical evidence is approximately 10:1.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 1 |
| /sign-up/ | 1 | 1 |
| /savings-card/ | 1 | 1 |
| /fm/ | 1 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"@id": "https://www.lyrica.com",
"url": "https://www.lyrica.com",
"inLanguage": "en-US",
"name": "LYRICA may help you on your path to symptom relief",
"description": "Learn about LYRICA and its FDA-approved uses, including fibromyalgia, diabetic nerve pain, spinal cord injury nerve pain, pain after shingles, and partial-onset seizures.",
"about": [
{
"@type": "MedicalCondition",
"name": "Fibromyalgia"
},
{
"@type": "MedicalCondition",
"name": "Diabetic nerve pain"
},
{
"@type": "MedicalCondition",
"name": "Spinal cord injury nerve pain"
},
{
"@type": "MedicalCondition",
"name": "Pain after shingles"
},
{
"@type": "MedicalCondition",
"name": "Partial-onset seizures"
}
],
"publisher": {
"@type": "Organization",
"name": "Viatris",
"url": "https://www.viatris.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.viatris.com/-/media/project/common/viatris/viatris-logo_withouttm.svg"
}
},
"isPartOf": {
"@type": "WebSite",
"@id": "https://www.lyrica.com"
}
},
{
"@type": "Organization",
"name": "Viatris",
"url": "https://www.viatris.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.viatris.com/-/media/project/common/viatris/viatris-logo_withouttm.svg"
}
},
{
"@type": "SiteNavigationElement",
"name": "Top navigation",
"inLanguage": "en-US",
"hasPart": [
{
"@type": "SiteNavigationElement",
"name": "Important Safety Information",
"url": "https://www.lyrica.com"
},
{
"@type": "SiteNavigationElement",
"name": "Full Prescribing Information",
"url": "https://www.lyrica.com"
},
{
"@type": "SiteNavigationElement",
"name": "Medication Guide",
"url": "https://www.lyrica.com"
}
]
},
{
"@type": "ItemList",
"name": "FDA-approved conditions treated with LYRICA",
"itemListOrder": "Unordered",
"numberOfItems": 5,
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Fibromyalgia"
},
{
"@type": "ListItem",
"position": 2,
"name": "Diabetic nerve pain"
},
{
"@type": "ListItem",
"position": 3,
"name": "Spinal cord injury nerve pain"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pain after shingles"
},
{
"@type": "ListItem",
"position": 5,
"name": "Partial-onset seizures"
}
]
}
]
}
This page presents a snapshot of public data from Lyrica (Viatris Inc.), captured on May 31, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Lyrica (Viatris Inc.): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://lyrica.com to view the most current version of its content and see directly what this company is about and what it offers.